日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bovine 60S ribosomal protein L7a (RPL7A) CSB-YP647203BO
CSB-EP647203BO
CSB-BP647203BO
CSB-MP647203BO
CSB-EP647203BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Centromere protein S (APITD1) CSB-YP647204BO
CSB-EP647204BO
CSB-BP647204BO
CSB-MP647204BO
CSB-EP647204BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Enoyl-CoA hydratase domain-containing protein 2, mitochondrial (ECHDC2), partial CSB-YP647205BO
CSB-EP647205BO
CSB-BP647205BO
CSB-MP647205BO
CSB-EP647205BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Electron transfer flavoprotein subunit beta (ETFB) CSB-YP647206BO
CSB-EP647206BO
CSB-BP647206BO
CSB-MP647206BO
CSB-EP647206BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine ADP-ribosylation factor-like protein 3 (ARL3) CSB-YP647207BO
CSB-EP647207BO
CSB-BP647207BO
CSB-MP647207BO
CSB-EP647207BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Coiled-coil domain-containing protein 86 (CCDC86) CSB-YP647208BO
CSB-EP647208BO
CSB-BP647208BO
CSB-MP647208BO
CSB-EP647208BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dog Heat shock 70 kDa protein 4 (HSPA4), partial CSB-YP647209DO
CSB-EP647209DO
CSB-BP647209DO
CSB-MP647209DO
CSB-EP647209DO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nasua nasua NADH-ubiquinone oxidoreductase chain 2 (MT-ND2), partial CSB-YP647210NAV
CSB-EP647210NAV
CSB-BP647210NAV
CSB-MP647210NAV
CSB-EP647210NAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dog Palmitoyltransferase ZDHHC5 (ZDHHC5), partial CSB-YP647211DO1
CSB-EP647211DO1
CSB-BP647211DO1
CSB-MP647211DO1
CSB-EP647211DO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Macoilin-1 (tmem57a), partial CSB-YP647212DIL1
CSB-EP647212DIL1
CSB-BP647212DIL1
CSB-MP647212DIL1
CSB-EP647212DIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Hydroxysteroid dehydrogenase-like protein 2 (Hsdl2) CSB-YP647213MO
CSB-EP647213MO
CSB-BP647213MO
CSB-MP647213MO
CSB-EP647213MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Horse Calcium-activated chloride channel regulator 1 (CLCA1), partial CSB-YP647214HO
CSB-EP647214HO
CSB-BP647214HO
CSB-MP647214HO
CSB-EP647214HO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Vacuolar protein sorting/targeting protein 10 (vps10), partial CSB-YP647215DPA
CSB-EP647215DPA
CSB-BP647215DPA
CSB-MP647215DPA
CSB-EP647215DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Adenylyltransferase and sulfurtransferase uba4 (uba4) CSB-YP647216DPA
CSB-EP647216DPA
CSB-BP647216DPA
CSB-MP647216DPA
CSB-EP647216DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable mannan endo-1,4-beta-mannosidase A (manA) CSB-YP647217DPA
CSB-EP647217DPA
CSB-BP647217DPA
CSB-MP647217DPA
CSB-EP647217DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Protein sip5 (sip5), partial CSB-YP647218DPA
CSB-EP647218DPA
CSB-BP647218DPA
CSB-MP647218DPA
CSB-EP647218DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Polyadenylation factor subunit 2 (pfs2), partial CSB-YP647219DPA
CSB-EP647219DPA
CSB-BP647219DPA
CSB-MP647219DPA
CSB-EP647219DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Sterol 3-beta-glucosyltransferase (atg26), partial CSB-YP647220DPA
CSB-EP647220DPA
CSB-BP647220DPA
CSB-MP647220DPA
CSB-EP647220DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Mitochondrial zinc maintenance protein 1, mitochondrial (MZM1) CSB-YP647221DPA
CSB-EP647221DPA
CSB-BP647221DPA
CSB-MP647221DPA
CSB-EP647221DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable rhamnogalacturonase A (rhgA) CSB-YP647222DPA
CSB-EP647222DPA
CSB-BP647222DPA
CSB-MP647222DPA
CSB-EP647222DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×